EarlySign and Geisinger partner on AI-based detection of disease risk

Geisinger and EarlySign will leverage AI technology to detect acute and chronic diseases. Credit: Gerd Altmann from Pixabay.



  • EarlySign, Geisinger partner on AI-based detection of diseases